Bio Venture IR Pitches and One-on-One Investor Meetings
to Be Held at Hanmi C&C Square on July 15

Hanmi Pharmaceutical announced on July 3 that it will co-host the 'Hanmi × Kiwoom Bio Innovation Day' with Kiwoom Securities on July 15 at Hanmi C&C Square in Songpa-gu, Seoul. This event is an open innovation forum designed to connect bio ventures with investors, with the goal of revitalizing the domestic bio venture ecosystem.


Hanmi Pharmaceutical and Kiwoom Securities plan to operate this event as a platform to introduce the technological competitiveness and R&D capabilities of bio ventures to the market, while also serving as a practical connection point with investors and industry stakeholders. Through this, promising bio ventures are expected to broaden their networks with venture capital firms, private equity funds, securities companies, and strategic investors, thereby seeking concrete opportunities for investment and business collaboration.

Hanmi Pharm will jointly host the "Hanmi × Kiwoom Bio Innovation Day" with Kiwoom Securities on the 15th of this month at Hanmi C&C Square in Songpa-gu, Seoul. Hanmi Pharm

Hanmi Pharm will jointly host the "Hanmi × Kiwoom Bio Innovation Day" with Kiwoom Securities on the 15th of this month at Hanmi C&C Square in Songpa-gu, Seoul. Hanmi Pharm

View original image

The event will take place from 9:00 a.m. to 4:30 p.m. It will begin with an opening address by Hanmi Pharmaceutical CEO Hwang Sangyeon, followed by IR pitch sessions for bio ventures, and will continue with one-on-one meeting sessions between participating companies and investors.


Participating in the IR pitch sessions are leading domestic bio ventures such as DeepCardio, Refine, Meditulip, CN Cure, Aerobio, SNE Bio, ODEN, Autotelic Bio, Portray, and Huron. Each company will present its pipeline, core technologies, and commercialization strategies to investors and industry representatives.


This 'Bio Innovation Day' is characterized by its integration of presentations and meetings, enabling promising bio ventures to effectively highlight their technological strengths and directly engage with interested investors.


The aim is for the event to become a representative open innovation platform in the pharmaceutical and bio sectors that continuously connects promising bio ventures with investors, rather than remaining a one-off event.


Participating companies were selected after a comprehensive evaluation of their market potential and expertise by an external panel of judges composed of Kiwoom Securities and relevant industry experts. Hanmi Pharmaceutical, together with Kiwoom Securities, plans to actively discover promising bio ventures and support investment opportunities.



A Hanmi Pharmaceutical official stated, "Hanmi × Kiwoom Bio Innovation Day was designed to bring together promising bio ventures and investors in one place to share technologies and potential, and to seek practical opportunities for collaboration," adding, "We will continue to develop this as a connecting platform that contributes to the vitalization of the domestic pharmaceutical and bio ecosystem."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing